Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » Top Stories

Top Stories

Recent articles that are of ongoing interest...

Recent Articles

  $147 Million Wuhan Healthcare Fund Formed by Leading VC Principals
  BeiGene Signs Blockbuster $1.4 Billion Deal with Celgene for PD-1 Asset
  Sinobioway Raises Offer for Vaccine Maker Sinovac to $459 Million
  Australia's CSL Buys 80% Stake in China Blood Products Company for $352 Million
  WuXi Biologics Prices Hong Kong IPO at $511 Million
  Zai Lab Files to Raise $150 Million for Venture Fund
  Sinobioway Enters $50 Million Deal for Five BioAtla CAB Candidates
  Otsuka to Pay $865 Million For Europe and China Rights to Akebia's Anemia Treatment
  Ping An Forms $1 Billion Global Investment Fund for Fin-Tec and Healthcare Startups
  WuXi NextCODE Raises $75 Million for Genomics Operations